help button home button Am J Pathol JNCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bronner, M. P.
Right arrow Articles by Furth, E. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bronner, M. P.
Right arrow Articles by Furth, E. E.

American Journal of Pathology, Vol 146, 20-26, Copyright © 1995 by American Society for Investigative Pathology


REGULAR ARTICLES

The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model

MP Bronner, C Culin, JC Reed and EE Furth
Department of Pathology, University of Washington Medical Center, Seattle.

We report overexpression of the proto-oncogene bcl-2 in gastrointestinal adenocarcinoma and its precursor lesions. The bcl-2 proto-oncogene is centrally involved in the oncogenesis of human follicular lymphoma via a chromosomal translocation t(14;18)(q32;q21) and is also expressed in the epithelial regenerative compartment or the basal crypts of the normal colon and small intestine. We describe an immunohistochemical analysis of fixed, paraffin-embedded tissue using both a polyclonal rabbit and a monoclonal mouse antibody to the Bcl-2 protein. In addition to confirming bcl-2 expression in normal colonic and small intestinal crypts, we also observed expression in the gastric epithelial regenerative compartment, the mucous neck region. No increased expression was found in nonneoplastic or inflammatory gastrointestinal conditions, including ulcerative colitis, Crohn's disease, or inflammatory or hamartomatous polyps. Increased bcl-2 expression, however, was present in hyperplastic colonic polyps and in the majority of dysplastic lesions, from the earliest precursors through large adenomas, high grade flat dysplasia, and adenocarcinoma, all in comparison with adjacent internal control normal epithelium. Increased expression was present in dysplastic glandular lesions from all gastrointestinal sites, including colon, small bowel, and stomach. Furthermore, bcl-2 expression was frequently abnormal in nondysplastic epithelium surrounding dysplastic lesions, suggesting that altered expression occurred before the development of morphological dysplasia. Specifically, directly contiguous morphologically nondysplastic epithelium often showed abnormal bcl-2 expression throughout the full length of the crypt-villus axis. This expression pattern gradually diminished to involve only the crypt base (the normal pattern of expression), proceeding away from malignant or dysplastic lesions. Abnormal bcl-2 immunoreactivity in 1), the earliest precursor dysplastic lesions and its persistence throughout neoplastic progression and 2), contiguous morphologically unaltered nondysplastic epithelium suggests that bcl-2 alterations occur early during the morphological and molecular sequence of events leading to gastrointestinal epithelial neoplasia.


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. L. Campbell, A. McTiernan, S. S. Li, B. E. Sorensen, Y. Yasui, J. W. Lampe, I. B. King, C. M. Ulrich, R. E. Rudolph, M. L. Irwin, et al.
Effect of a 12-Month Exercise Intervention on the Apoptotic Regulating Proteins Bax and Bcl-2 in Colon Crypts: A Randomized Controlled Trial
Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1767 - 1774.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
Abstracts
Gut, April 1, 2006; 55(suppl_2): a1 - a119.
[Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Lu, M. S. Caplan, A. P. Saraf, D. Li, L. Adler, X. Liu, and T. Jilling
Platelet-activating factor-induced apoptosis is blocked by Bcl-2 in rat intestinal epithelial cells
Am J Physiol Gastrointest Liver Physiol, February 1, 2004; 286(2): G340 - G350.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
N. K. Kim, J. K. Park, K. Y. Lee, W. I. Yang, S. H. Yun, J. Sung, and J. S. Min
p53, BCL-2, and Ki-67 Expression According to Tumor Response After Concurrent Chemoradiotherapy for Advanced Rectal Cancer
Ann. Surg. Oncol., June 1, 2001; 8(5): 418 - 424.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. N. Agoff, T. A. Brentnall, D. A. Crispin, S. L. Taylor, S. Raaka, R. C. Haggitt, M. W. Reed, I. A. Afonina, P. S. Rabinovitch, A. C. Stevens, et al.
The Role of Cyclooxygenase 2 in Ulcerative Colitis-Associated Neoplasia
Am. J. Pathol., September 1, 2000; 157(3): 737 - 745.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
N. L. Jones, A. Islur, R. Haq, M. Mascarenhas, M. A. Karmali, M. H. Perdue, B. W. Zanke, and P. M. Sherman
Escherichia coli Shiga toxins induce apoptosis in epithelial cells that is regulated by the Bcl-2 family
Am J Physiol Gastrointest Liver Physiol, May 1, 2000; 278(5): G811 - G819.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Dong, W. Wang, F. Wang, M. Stoner, J. C. Reed, M. Harigai, I. Samudio, M. P. Kladde, C. Vyhlidal, and S. Safe
Mechanisms of Transcriptional Activation of bcl-2 Gene Expression by 17beta -Estradiol in Breast Cancer Cells
J. Biol. Chem., November 5, 1999; 274(45): 32099 - 32107.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Sarbia, C. Loberg, M. Wolter, J. Arjumand, H. Heep, G. Reifenberger, and H. E. Gabbert
Expression of Bcl-2 and Amplification of c-myc Are Frequent in Basaloid Squamous Cell Carcinomas of the Esophagus
Am. J. Pathol., October 1, 1999; 155(4): 1027 - 1032.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
G Nardone, S Staibano, A Rocco, E Mezza, F P D'Armiento, L Insabato, A Coppola, G Salvatore, A Lucariello, N Figura, et al.
Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis
Gut, June 1, 1999; 44(6): 789 - 799.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. F. McEntee, C.-H. Chiu, and J. Whelan
Relationship of ß-catenin and Bcl-2 expression to sulindac-induced regression of intestinal tumors in Min mice
Carcinogenesis, April 1, 1999; 20(4): 635 - 640.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
M. H. Mostafa, S. A. Sheweita, and P. J. O'Connor
Relationship between Schistosomiasis and Bladder Cancer
Clin. Microbiol. Rev., January 1, 1999; 12(1): 97 - 111.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
B. A. Jones and G. J. Gores
Physiology and pathophysiology of apoptosis in epithelial cells of the liver, pancreas, and intestine
Am J Physiol Gastrointest Liver Physiol, December 1, 1997; 273(6): G1174 - G1188.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
C. M. Coopersmith, C. Chandrasekaran, M. S. McNevin, and J. I. Gordon
Bi-transgenic Mice Reveal that K-rasVal12 Augments a p53-independent Apoptosis When Small Intestinal Villus Enterocytes Reenter the Cell Cycle
J. Cell Biol., July 14, 1997; 138(1): 167 - 179.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Society for Investigative Pathology.